- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01176331
Outcomes of 20 and 23-gauge Combined Transconjunctival Pars Plana Vitrectomy
August 5, 2010 updated by: Kocaeli University
In a retrospective study, a combined 20 and 23-gauge pars plana vitrectomy procedure was performed in 21 eyes for various indications and proposed as a transition procedure to 23-gauge transconjunctival vitrectomy.
Through use of combination of procedures postoperative complications, surgical trauma and healing time was decreased; operating time was reduced; costs were decreased.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Kocaeli, Turkey
- Department of ophthalmology,Hospital of Faculty of Medicine, Kocaeli University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
44 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients who were in the range 44 to 80 years, who had to undergo vitrectomy operation with different diagnosis were included in the study.
Each participant had a complete ophthalmological examination which included best-corrected visual acuity (BCVA), slit lamp examination with and without pupil dilation, intraocular pressure (IOP) measurement with applanation tonometry and stereoscopic evaluation of the ocular fundus before decision of operation.
Description
Inclusion Criteria:
- eyes requiring pars plana vitrectomy for various indications: such as dropped lens, intraocular blood, retinal detachments...etc.
Exclusion Criteria:
- patients who did not observed periodically during postoperative period.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
vitrectomy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
visual acuity
|
Secondary Outcome Measures
Outcome Measure |
---|
postoperative complications
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
August 3, 2010
First Submitted That Met QC Criteria
August 5, 2010
First Posted (Estimate)
August 6, 2010
Study Record Updates
Last Update Posted (Estimate)
August 6, 2010
Last Update Submitted That Met QC Criteria
August 5, 2010
Last Verified
July 1, 2010
More Information
Terms related to this study
Other Study ID Numbers
- KOU-8487358664
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vitrectomy
-
VISTA OphthalmicsCBCC Global ResearchActive, not recruitingVitrectomyUnited States
-
ThromboGenicsCompletedVitrectomyUnited States
-
Asociación para Evitar la Ceguera en MéxicoUnknown
-
Innovative MedicalCompletedVitrectomyUnited States
-
Vanderbilt University Medical CenterAlcon ResearchCompleted
-
ThromboGenicsCompleted
-
Alcon ResearchCompleted
-
Universitaire Ziekenhuizen KU LeuvenTerminated
-
AllerganCompletedVitrectomyUnited States, Czech Republic
-
Eyegate Pharmaceuticals, Inc.Completed
Clinical Trials on 20 and 23 gauge pars plana vitrectomy
-
Benha UniversityCompletedCataract | Endophthalmitis | Retinal Detachment | Vitreous DetachmentEgypt
-
National Taiwan University HospitalCompleted
-
Ain Shams UniversityCompleted
-
Peregrine Eye and Laser InstituteAlcon ResearchRecruitingVitreous Hemorrhage | Retinal Detachment | Epiretinal Membrane | Vitrectomy | Macular Holes | Dislocated Intraocular Lens Into Vitreous | Retained Lens FragmentsPhilippines
-
Benha UniversityRecruiting
-
PharmaBio CorporationRecruitingMyopic Chorioretinal AtrophyJapan
-
Ospedale Policlinico San MartinoRecruitingRetinal Detachment | PArs Plana Vitrectomy | Silicone Oil Droplets on Intraocular LensItaly
-
Ospedale Policlinico San MartinoRecruiting
-
Omer Othman AbdullahTerminated
-
Minia UniversityCompleted